Simon J. Graham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Simon J. Graham has a total of 192 co-authors. Here are the top co-authors by number of shared publications:
Nathan W. Churchill
Brain Health and Wellness Research Program, St. Michael’s Hospital, Unity Health Toronto, Toronto, Canada
10 shared publications- Tom A. Schweizer
Neuroscience Research Program, Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada
6 shared publications - Tom A. Schweizer
Neuroscience Research Program, St. Michael’s Hospital, Toronto, ON, Canada
6 shared publications Tom A. Schweizer
Brain Health and Wellness Research Program, St. Michael’s Hospital, Unity Health Toronto, Toronto, Canada
5 shared publications- Michael G. Hutchison
Centre for Sport-Related Concussion Research, Innovation, and Knowledge, University of Toronto, Toronto, ON, Canada
4 shared publications - Sanjay Kalra
Division of Neurology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
4 shared publications
Latest Publications
- 18 September 2026
- Published by Wolters Kluwer Health in Neurosurgery
Optimized Brain Functional MRI for Patients With Deep Brain Stimulation Systems
BACKGROUND AND OBJECTIVES: Deep brain stimulation (DBS) is an established neuromodulation therapy for Parkinson disease and other neurological disorders. Active DBS–functional MRI (fMRI) enables visualization of circuit engagement and may provide objective biomarkers of therapeutic efficacy, yet susceptibility artifacts compromise data quality. The aim of this study was to develop optimized blood oxygenation-level–dependent (BOLD) fMRI protocols for DBS patients by adjusting operator-accessible parameters to mitigate susceptibility artifacts while preserving image quality. METHODS: In vitro testing was performed on a 3-dimensional–printed anthropomorphic phantom simulating a patient with a 3T-conditional directional DBS system. We evaluated operator-adjustable parameters—spatial resolution, GeneRalized Autocalibrating Partially Parallel Acquisitions (GRAPPA) acceleration, echo time, and simultaneous multislice acceleration—for their effects on artifact volume and temporal signal-to-noise ratio (tSNR). As exploratory analysis, optimized protocols were demonstrated in subthalamic nucleus-DBS patients (n = 3). RESULTS: Higher spatial resolution and GRAPPA acceleration significantly reduced artifact volume (isotropic voxel size: 95% CI [1620.2, 2605.6], P < .001; GRAPPA: 95% CI [−1169.7, −749.0], P < .001) but also lowered tSNR (isotropic voxel size: 95% CI [62.5, 77.1], P < .001; GRAPPA: 95% CI [−17.3, −12.7], P < .001). Echo time adjustments had smaller yet significant effects on both artifact reduction (95% CI [127.3, 174.4], P < .001) and tSNR (95% CI [−1.3, −0.6], P < .001). Three optimized fMRI protocols were developed: (1) high spatial resolution, (2) balanced high resolution and whole-brain coverage (both with standard temporal resolution), and (3) high temporal resolution at standard spatial resolution (with reduced inner coil volume). Patients were scanned with the second protocol variant and total DBS artifact volume reduced by 45.1% ± 2.4% compared with clinical BOLD fMRI. CONCLUSION: Optimized BOLD fMRI protocols effectively minimized susceptibility artifacts while preserving image quality, enabling reliable functional imaging in DBS patients—a timely advancement given the rise in DBS implants and introduction of directional stimulation systems.
- 18 September 2026
- Published by Wolters Kluwer Health in Neurosurgery
Optimized Brain Functional MRI for Patients With Deep Brain Stimulation Systems
BACKGROUND AND OBJECTIVES: Deep brain stimulation (DBS) is an established neuromodulation therapy for Parkinson disease and other neurological disorders. Active DBS–functional MRI (fMRI) enables visualization of circuit engagement and may provide objective biomarkers of therapeutic efficacy, yet susceptibility artifacts compromise data quality. The aim of this study was to develop optimized blood oxygenation-level–dependent (BOLD) fMRI protocols for DBS patients by adjusting operator-accessible parameters to mitigate susceptibility artifacts while preserving image quality. METHODS: In vitro testing was performed on a 3-dimensional–printed anthropomorphic phantom simulating a patient with a 3T-conditional directional DBS system. We evaluated operator-adjustable parameters—spatial resolution, GeneRalized Autocalibrating Partially Parallel Acquisitions (GRAPPA) acceleration, echo time, and simultaneous multislice acceleration—for their effects on artifact volume and temporal signal-to-noise ratio (tSNR). As exploratory analysis, optimized protocols were demonstrated in subthalamic nucleus-DBS patients (n = 3). RESULTS: Higher spatial resolution and GRAPPA acceleration significantly reduced artifact volume (isotropic voxel size: 95% CI [1620.2, 2605.6], P < .001; GRAPPA: 95% CI [−1169.7, −749.0], P < .001) but also lowered tSNR (isotropic voxel size: 95% CI [62.5, 77.1], P < .001; GRAPPA: 95% CI [−17.3, −12.7], P < .001). Echo time adjustments had smaller yet significant effects on both artifact reduction (95% CI [127.3, 174.4], P < .001) and tSNR (95% CI [−1.3, −0.6], P < .001). Three optimized fMRI protocols were developed: (1) high spatial resolution, (2) balanced high resolution and whole-brain coverage (both with standard temporal resolution), and (3) high temporal resolution at standard spatial resolution (with reduced inner coil volume). Patients were scanned with the second protocol variant and total DBS artifact volume reduced by 45.1% ± 2.4% compared with clinical BOLD fMRI. CONCLUSION: Optimized BOLD fMRI protocols effectively minimized susceptibility artifacts while preserving image quality, enabling reliable functional imaging in DBS patients—a timely advancement given the rise in DBS implants and introduction of directional stimulation systems.
- Open Access
- 14 May 2026
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 96 (3) , 1219-1234
SelExNet : A Self‐Supervised Physics‐Informed Framework for Multi‐Channel Joint RF and Gradient Waveform Optimization in 2D Spatially Selective Excitation
Purpose To introduce SelExNet: a self-supervised framework for two-dimensional spatially selective excitation that jointly optimizes radiofrequency (RF) pulses and gradient waveforms, and extends to multi-channel transmission MRI. Methods Building on prior RF-only and joint RF-gradient optimization approaches, SelExNet couples neural RF and gradient generators with a differentiable Bloch simulator to enable self-supervised pulse optimization without requiring pre-designed target pulses. The framework jointly designs RF pulses and parameterized variable-density spiral gradient waveforms for both single- and multi-channel transmission, with patient-specific adaptation using measured, previously unseen and maps. Results Joint optimization of RF and gradients improved excitation fidelity compared to RF-only optimization. In phantom experiments with synthetic field maps, pretrained pulses showed distortions, whereas fine-tuned pulses restored geometry and uniformity. In vivo studies demonstrated anatomically precise excitation, with fine-tuning improving sharpness and reducing off-target signal. Conclusion The proposed framework enables joint RF-gradient design and extends self-supervised pulse optimization to multi-channel transmission MRI. SelExNet achieves high-fidelity, anatomically precise excitation and demonstrates robustness to field inhomogeneities, offering a scalable pathway for ultra-high field imaging.- 14 May 2026
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 96 (3) , 1219-1234
Open AccessSelExNet : A Self‐Supervised Physics‐Informed Framework for Multi‐Channel Joint RF and Gradient Waveform Optimization in 2D Spatially Selective Excitation
Purpose To introduce SelExNet: a self-supervised framework for two-dimensional spatially selective excitation that jointly optimizes radiofrequency (RF) pulses and gradient waveforms, and extends to multi-channel transmission MRI. Methods Building on prior RF-only and joint RF-gradient optimization approaches, SelExNet couples neural RF and gradient generators with a differentiable Bloch simulator to enable self-supervised pulse optimization without requiring pre-designed target pulses. The framework jointly designs RF pulses and parameterized variable-density spiral gradient waveforms for both single- and multi-channel transmission, with patient-specific adaptation using measured, previously unseen and maps. Results Joint optimization of RF and gradients improved excitation fidelity compared to RF-only optimization. In phantom experiments with synthetic field maps, pretrained pulses showed distortions, whereas fine-tuned pulses restored geometry and uniformity. In vivo studies demonstrated anatomically precise excitation, with fine-tuning improving sharpness and reducing off-target signal. Conclusion The proposed framework enables joint RF-gradient design and extends self-supervised pulse optimization to multi-channel transmission MRI. SelExNet achieves high-fidelity, anatomically precise excitation and demonstrates robustness to field inhomogeneities, offering a scalable pathway for ultra-high field imaging. - Open Access
- 28 October 2025
- Published by Elsevier in Brain Stimulation
- Vol. 18 (6) , 2054-2066
Human applications of transcranial temporal interference stimulation: A systematic review
- 28 October 2025
- Published by Elsevier in Brain Stimulation
- Vol. 18 (6) , 2054-2066
Open AccessHuman applications of transcranial temporal interference stimulation: A systematic review
- 14 August 2025
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 42 (15-16) , 1287-1301
Post-Concussion Changes in the Functional Brain Connectome Relative to Pre-Injury Baseline: A Prospective Observational Study
There is growing concern about the long-term health consequences of concussion, stemming from its high incidence and evidence of post-injury sequelae. This has raised critical questions about clinical assessments of concussion recovery, and whether brain function has fully recovered at medical clearance. The major knowledge gap is only partly addressed by conventional cross-sectional neuroimaging studies, due to a lack of pre-injury baseline imaging. To address this gap, 187 university-level athletes had resting-state functional magnetic resonance imaging collected at pre-season baseline. Of this cohort, 25 were later concussed, with imaging at early symptomatic injury (SYM), medical clearance to return to play (RTP), and 1–3 months post-RTP (POST). An additional 27 uninjured athletes were reimaged as controls. Brain maps were parcellated, and functional connectivity was measured between regions. Mixed models assessed connectivity change at each post-concussion session, along with the moderating effect of time to medical clearance. Concussed athletes had a significantly altered connectome, with predominantly reduced frontotemporal connectivity. Effects were most extensive at SYM, with diminishing but significant effects at RTP and POST, all of which exceeded uninjured control variability (all z ≤ −3.71, p ≤ 0.001). For participants with a longer time to medical clearance, more extensive connectivity decreases were also seen at all post-concussion imaging sessions. These findings provide direct evidence that functional brain recovery lags beyond medical clearance, with more pronounced effects among individuals who have prolonged clinical recovery. Such prospective analyses provide a unique window into biological recovery processes, with major implications for the clinical management of concussion.
- 14 August 2025
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 42 (15-16) , 1287-1301
Post-Concussion Changes in the Functional Brain Connectome Relative to Pre-Injury Baseline: A Prospective Observational Study
There is growing concern about the long-term health consequences of concussion, stemming from its high incidence and evidence of post-injury sequelae. This has raised critical questions about clinical assessments of concussion recovery, and whether brain function has fully recovered at medical clearance. The major knowledge gap is only partly addressed by conventional cross-sectional neuroimaging studies, due to a lack of pre-injury baseline imaging. To address this gap, 187 university-level athletes had resting-state functional magnetic resonance imaging collected at pre-season baseline. Of this cohort, 25 were later concussed, with imaging at early symptomatic injury (SYM), medical clearance to return to play (RTP), and 1–3 months post-RTP (POST). An additional 27 uninjured athletes were reimaged as controls. Brain maps were parcellated, and functional connectivity was measured between regions. Mixed models assessed connectivity change at each post-concussion session, along with the moderating effect of time to medical clearance. Concussed athletes had a significantly altered connectome, with predominantly reduced frontotemporal connectivity. Effects were most extensive at SYM, with diminishing but significant effects at RTP and POST, all of which exceeded uninjured control variability (all z ≤ −3.71, p ≤ 0.001). For participants with a longer time to medical clearance, more extensive connectivity decreases were also seen at all post-concussion imaging sessions. These findings provide direct evidence that functional brain recovery lags beyond medical clearance, with more pronounced effects among individuals who have prolonged clinical recovery. Such prospective analyses provide a unique window into biological recovery processes, with major implications for the clinical management of concussion.
- 8 April 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (7) , e213374
Post-Concussion Brain Changes Relative to Pre-Injury White Matter and Cerebral Blood Flow
Medical clearance for return to play (RTP) after sports-related concussion is based on clinical assessment. It is unknown whether brain physiology has entirely returned to preinjury baseline at the time of clearance. In this longitudinal study, we assessed whether concussed individuals show functional and structural MRI brain changes relative to preinjury levels that persist beyond medical clearance. Secondary objectives were to test whether postconcussion changes exceed uninjured brain variability and to correlate MRI findings with clinical recovery time. For this prospective observational study, healthy athletes without a history of psychiatric, neurologic, or sensory-motor conditions were recruited from a single university sport medicine clinic. Clinical and MRI data were collected at preseason baseline, and those who were later concussed were reassessed at 1-7 days after injury, RTP, 1-3 months after RTP, and 1 year after RTP. A demographically matched control cohort of uninjured athletes was also reassessed at their subsequent preseason baseline. Primary outcomes were postconcussion changes in MRI measures of cerebral blood flow (CBF), white matter mean diffusivity (MD), and fractional anisotropy (FA), evaluated using mixed models. Secondary outcomes were group differences in MRI change scores and correlations of change scores with days to RTP. Of the 187 athletes enrolled in the study, 25 had concussion with follow-up imaging (20.3 ± 1.5 years, 56% male, 44% female) and were compared with 27 controls (19.7 ± 1.8 years, 44% male, 56% female). Concussed athletes showed statistically significant changes from baseline, including decreased frontoinsular CBF (mean and 95% CI -8.97 [-12.80, -5.01] mL/100 g/minute, z = -4.53), along with increased MD (1.94 × 10-5 [1.26, 2.69] × 10-5, z = 5.48) and reduced FA (-7.30 × 10-3 [-9.80, -5.05] × 10-3, z = -6.07) in the corona radiata and internal capsule. Effects persisted beyond RTP, although only CBF changes exceeded longitudinal variability in controls. For participants with longer recovery periods, significantly greater changes in medial temporal CBF were also seen (ρ = 0.64 [0.44, 0.81], z = 6.80). This study provides direct evidence of persistent postconcussion changes in CBF and white matter at RTP and up to 1 year later. These results support incomplete recovery of brain physiology at medical clearance, with secondary analyses emphasizing the sensitivity of CBF to clinical recovery.
- 8 April 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (7) , e213374
Post-Concussion Brain Changes Relative to Pre-Injury White Matter and Cerebral Blood Flow
Medical clearance for return to play (RTP) after sports-related concussion is based on clinical assessment. It is unknown whether brain physiology has entirely returned to preinjury baseline at the time of clearance. In this longitudinal study, we assessed whether concussed individuals show functional and structural MRI brain changes relative to preinjury levels that persist beyond medical clearance. Secondary objectives were to test whether postconcussion changes exceed uninjured brain variability and to correlate MRI findings with clinical recovery time. For this prospective observational study, healthy athletes without a history of psychiatric, neurologic, or sensory-motor conditions were recruited from a single university sport medicine clinic. Clinical and MRI data were collected at preseason baseline, and those who were later concussed were reassessed at 1-7 days after injury, RTP, 1-3 months after RTP, and 1 year after RTP. A demographically matched control cohort of uninjured athletes was also reassessed at their subsequent preseason baseline. Primary outcomes were postconcussion changes in MRI measures of cerebral blood flow (CBF), white matter mean diffusivity (MD), and fractional anisotropy (FA), evaluated using mixed models. Secondary outcomes were group differences in MRI change scores and correlations of change scores with days to RTP. Of the 187 athletes enrolled in the study, 25 had concussion with follow-up imaging (20.3 ± 1.5 years, 56% male, 44% female) and were compared with 27 controls (19.7 ± 1.8 years, 44% male, 56% female). Concussed athletes showed statistically significant changes from baseline, including decreased frontoinsular CBF (mean and 95% CI -8.97 [-12.80, -5.01] mL/100 g/minute, z = -4.53), along with increased MD (1.94 × 10-5 [1.26, 2.69] × 10-5, z = 5.48) and reduced FA (-7.30 × 10-3 [-9.80, -5.05] × 10-3, z = -6.07) in the corona radiata and internal capsule. Effects persisted beyond RTP, although only CBF changes exceeded longitudinal variability in controls. For participants with longer recovery periods, significantly greater changes in medial temporal CBF were also seen (ρ = 0.64 [0.44, 0.81], z = 6.80). This study provides direct evidence of persistent postconcussion changes in CBF and white matter at RTP and up to 1 year later. These results support incomplete recovery of brain physiology at medical clearance, with secondary analyses emphasizing the sensitivity of CBF to clinical recovery.
- Open Access
Test Platform for Developing New Optical Position Tracking Technology towards Improved Head Motion Correction in Magnetic Resonance Imaging
Optical tracking of head pose via fiducial markers has been proven to enable effective correction of motion artifacts in the brain during magnetic resonance imaging but remains difficult to implement in the clinic due to lengthy calibration and set up times. Advances in deep learning for markerless head pose estimation have yet to be applied to this problem because of the sub-millimetre spatial resolution required for motion correction. In the present work, two optical tracking systems are described for the development and training of a neural network: one marker-based system (a testing platform for measuring ground truth head pose) with high tracking fidelity to act as the training labels, and one markerless deep-learning-based system using images of the markerless head as input to the network. The markerless system has the potential to overcome issues of marker occlusion, insufficient rigid attachment of the marker, lengthy calibration times, and unequal performance across degrees of freedom (DOF), all of which hamper the adoption of marker-based solutions in the clinic. Detail is provided on the development of a custom moiré-enhanced fiducial marker for use as ground truth and on the calibration procedure for both optical tracking systems. Additionally, the development of a synthetic head pose dataset is described for the proof of concept and initial pre-training of a simple convolutional neural network. Results indicate that the ground truth system has been sufficiently calibrated and can track head pose with an error of <1 mm and <1°. Tracking data of a healthy, adult participant are shown. Pre-training results show that the average root-mean-squared error across the 6 DOF is 0.13 and 0.36 (mm or degrees) on a head model included and excluded from the training dataset, respectively. Overall, this work indicates excellent feasibility of the deep-learning-based approach and will enable future work in training and testing on a real dataset in the MRI environment.
Open AccessTest Platform for Developing New Optical Position Tracking Technology towards Improved Head Motion Correction in Magnetic Resonance Imaging
Optical tracking of head pose via fiducial markers has been proven to enable effective correction of motion artifacts in the brain during magnetic resonance imaging but remains difficult to implement in the clinic due to lengthy calibration and set up times. Advances in deep learning for markerless head pose estimation have yet to be applied to this problem because of the sub-millimetre spatial resolution required for motion correction. In the present work, two optical tracking systems are described for the development and training of a neural network: one marker-based system (a testing platform for measuring ground truth head pose) with high tracking fidelity to act as the training labels, and one markerless deep-learning-based system using images of the markerless head as input to the network. The markerless system has the potential to overcome issues of marker occlusion, insufficient rigid attachment of the marker, lengthy calibration times, and unequal performance across degrees of freedom (DOF), all of which hamper the adoption of marker-based solutions in the clinic. Detail is provided on the development of a custom moiré-enhanced fiducial marker for use as ground truth and on the calibration procedure for both optical tracking systems. Additionally, the development of a synthetic head pose dataset is described for the proof of concept and initial pre-training of a simple convolutional neural network. Results indicate that the ground truth system has been sufficiently calibrated and can track head pose with an error of <1 mm and <1°. Tracking data of a healthy, adult participant are shown. Pre-training results show that the average root-mean-squared error across the 6 DOF is 0.13 and 0.36 (mm or degrees) on a head model included and excluded from the training dataset, respectively. Overall, this work indicates excellent feasibility of the deep-learning-based approach and will enable future work in training and testing on a real dataset in the MRI environment.
- 8 May 2024
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (7) , 4540-4550
History of traumatic brain injury is associated with increased grey-matter loss in patients with mild cognitive impairment
Objectives To investigate whether a history of traumatic brain injury (TBI) is associated with greater long-term grey-matter loss in patients with mild cognitive impairment (MCI). Methods 85 patients with MCI were identified, including 26 with a previous history of traumatic brain injury (MCI[TBI-]) and 59 without (MCI[TBI+]). Cortical thickness was evaluated by segmenting T1-weighted MRI scans acquired longitudinally over a 2-year period. Bayesian multilevel modelling was used to evaluate group differences in baseline cortical thickness and longitudinal change, as well as group differences in neuropsychological measures of executive function. Results At baseline, the MCI[TBI+] group had less grey matter within right entorhinal, left medial orbitofrontal and inferior temporal cortex areas bilaterally. Longitudinally, the MCI[TBI+] group also exhibited greater longitudinal declines in left rostral middle frontal, the left caudal middle frontal and left lateral orbitofrontal areas sover the span of 2 years (median = 1–2%, 90%HDI [−0.01%: −0.001%], probability of direction (PD) = 90–99%). The MCI[TBI+] group also displayed greater longitudinal declines in Trail-Making-Test (TMT)-derived ratio (median: 0.737%, 90%HDI: [0.229%: 1.31%], PD = 98.8%) and differences scores (median: 20.6%, 90%HDI: [−5.17%: 43.2%], PD = 91.7%). Conclusions Our findings support the notion that patients with MCI and a history of TBI are at risk of accelerated neurodegeneration, displaying greatest evidence for cortical atrophy within the left middle frontal and lateral orbitofrontal frontal cortex. Importantly, these results suggest that long-term TBI-mediated atrophy is more pronounced in areas vulnerable to TBI-related mechanical injury, highlighting their potential relevance for diagnostic forms of intervention in TBI.
- 8 May 2024
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (7) , 4540-4550
History of traumatic brain injury is associated with increased grey-matter loss in patients with mild cognitive impairment
Objectives To investigate whether a history of traumatic brain injury (TBI) is associated with greater long-term grey-matter loss in patients with mild cognitive impairment (MCI). Methods 85 patients with MCI were identified, including 26 with a previous history of traumatic brain injury (MCI[TBI-]) and 59 without (MCI[TBI+]). Cortical thickness was evaluated by segmenting T1-weighted MRI scans acquired longitudinally over a 2-year period. Bayesian multilevel modelling was used to evaluate group differences in baseline cortical thickness and longitudinal change, as well as group differences in neuropsychological measures of executive function. Results At baseline, the MCI[TBI+] group had less grey matter within right entorhinal, left medial orbitofrontal and inferior temporal cortex areas bilaterally. Longitudinally, the MCI[TBI+] group also exhibited greater longitudinal declines in left rostral middle frontal, the left caudal middle frontal and left lateral orbitofrontal areas sover the span of 2 years (median = 1–2%, 90%HDI [−0.01%: −0.001%], probability of direction (PD) = 90–99%). The MCI[TBI+] group also displayed greater longitudinal declines in Trail-Making-Test (TMT)-derived ratio (median: 0.737%, 90%HDI: [0.229%: 1.31%], PD = 98.8%) and differences scores (median: 20.6%, 90%HDI: [−5.17%: 43.2%], PD = 91.7%). Conclusions Our findings support the notion that patients with MCI and a history of TBI are at risk of accelerated neurodegeneration, displaying greatest evidence for cortical atrophy within the left middle frontal and lateral orbitofrontal frontal cortex. Importantly, these results suggest that long-term TBI-mediated atrophy is more pronounced in areas vulnerable to TBI-related mechanical injury, highlighting their potential relevance for diagnostic forms of intervention in TBI.
- Open Access
- 23 October 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (11) , e3212
Persistent post‐COVID headache is associated with suppression of scale‐free functional brain dynamics in non‐hospitalized individuals
Introduction: Post‐acute coronavirus disease 2019 (COVID‐19) syndrome (PACS) is a growing concern, with headache being a particularly debilitating symptom with high prevalence. The long‐term effects of COVID‐19 and post‐COVID headache on brain function remain poorly understood, particularly among non‐hospitalized individuals. This study focused on the power‐law scaling behavior of functional brain dynamics, indexed by the Hurst exponent (H). This measure is suppressed during physiological and psychological distress and was thus hypothesized to be reduced in individuals with post‐COVID syndrome, with greatest reductions among those with persistent headache.Methods: Resting‐state blood oxygenation level‐dependent (BOLD) functional magnetic resonance imaging data were collected for 57 individuals who had COVID‐19 (32 with no headache, 14 with ongoing headache, 11 recovered) and 17 controls who had cold and flu‐like symptoms but tested negative for COVID‐19. Individuals were assessed an average of 4–5 months after COVID testing, in a cross‐sectional, observational study design.Results: No significant differences in H values were found between non‐headache COVID‐19 and control groups., while those with ongoing headache had significantly reduced H values, and those who had recovered from headache had elevated H values, relative to non‐headache groups. Effects were greatest in temporal, sensorimotor, and insular brain regions. Reduced H in these regions was also associated with decreased BOLD activity and local functional connectivity.Conclusions: These findings provide new insights into the neurophysiological mechanisms that underlie persistent post‐COVID headache, with reduced BOLD scaling as a potential biomarker that is specific to this debilitating condition.
- 23 October 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (11) , e3212
Open AccessPersistent post‐COVID headache is associated with suppression of scale‐free functional brain dynamics in non‐hospitalized individuals
Introduction: Post‐acute coronavirus disease 2019 (COVID‐19) syndrome (PACS) is a growing concern, with headache being a particularly debilitating symptom with high prevalence. The long‐term effects of COVID‐19 and post‐COVID headache on brain function remain poorly understood, particularly among non‐hospitalized individuals. This study focused on the power‐law scaling behavior of functional brain dynamics, indexed by the Hurst exponent (H). This measure is suppressed during physiological and psychological distress and was thus hypothesized to be reduced in individuals with post‐COVID syndrome, with greatest reductions among those with persistent headache.Methods: Resting‐state blood oxygenation level‐dependent (BOLD) functional magnetic resonance imaging data were collected for 57 individuals who had COVID‐19 (32 with no headache, 14 with ongoing headache, 11 recovered) and 17 controls who had cold and flu‐like symptoms but tested negative for COVID‐19. Individuals were assessed an average of 4–5 months after COVID testing, in a cross‐sectional, observational study design.Results: No significant differences in H values were found between non‐headache COVID‐19 and control groups., while those with ongoing headache had significantly reduced H values, and those who had recovered from headache had elevated H values, relative to non‐headache groups. Effects were greatest in temporal, sensorimotor, and insular brain regions. Reduced H in these regions was also associated with decreased BOLD activity and local functional connectivity.Conclusions: These findings provide new insights into the neurophysiological mechanisms that underlie persistent post‐COVID headache, with reduced BOLD scaling as a potential biomarker that is specific to this debilitating condition.
- Open Access
- 29 July 2023
- Published by Elsevier in Computerized Medical Imaging and Graphics
- Vol. 108, 102279
SF2Former: Amyotrophic lateral sclerosis identification from multi-center MRI data using spatial and frequency fusion transformer
- 29 July 2023
- Published by Elsevier in Computerized Medical Imaging and Graphics
- Vol. 108, 102279
Open AccessSF2Former: Amyotrophic lateral sclerosis identification from multi-center MRI data using spatial and frequency fusion transformer